Dr. Benjamin Heller
Ophthalmology (Ophthalmology Physician)
515 W Buckeye Rd Ste 104
Phoenix, AZ 85003
Who else practices at this address →
Maricopa County includes primary care (13% of residents) and dental (0% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 514
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
AZ license 007053 -
Family Medicine Physician
CA license 20A13378
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Eye Doctors of Arizona PLLC (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 514
- Services billed
- 1,719
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 174 | 104 |
| New patient office or other outpatient visit, 45-59 minutes | 147 | 147 |
| Established patient office or other outpatient visit, 30-39 minutes | 130 | 106 |
| Closure of tear duct opening using plug | 124 | 19 |
| Established patient complete exam of visual system | 89 | 77 |
| Imaging of retina | 80 | 55 |
| Established patient office or other outpatient visit, 20-29 minutes | 66 | 52 |
| Ultrasound scan to determine eye length and lens power | 48 | 46 |
| Established patient problem focused exam of visual system | 46 | 37 |
| Ct scan of cornea | 45 | 44 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Phoenix, AZ | 558 |
| Ofloxacin Other prescribers in Phoenix, AZ | 499 |
| Latanoprost Other prescribers in Phoenix, AZ | 240 |
| Brimonidine Tartrate Other prescribers in Phoenix, AZ | 72 |
| Neomycin-Polymyxin-Dexameth (neomycin/polymyxin b/dexametha) Other prescribers in Phoenix, AZ | 64 |
| Timolol Maleate Other prescribers in Phoenix, AZ | 51 |
| Lumigan (bimatoprost) Other prescribers in Phoenix, AZ | 35 |
| Dorzolamide Hcl Other prescribers in Phoenix, AZ | 17 |
| Fluorometholone Other prescribers in Phoenix, AZ | 16 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Phoenix, AZ | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 42 payments worth $8,204 in total to this clinician.
| Glaukos Corporation | $6,832 |
|---|---|
| Lensar, Inc. | $697 |
| Rxsight Inc | $232 |
| Bausch & Lomb Americas Inc. | $212 |
| Dompe US, Inc. | $95.30 |
| Boston Scientific Corporation | $66.73 |
| Johnson & Johnson Surgical Vision, Inc. | $26.72 |
| Alcon Vision LLC | $22.40 |
| Consulting Fee | $4,906 |
|---|---|
| Food and Beverage | $3,176 |
| Travel and Lodging | $122 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Glaukos Corporation May 21, 2025 | Consulting Fee Travoprost Intraocular Implant - iDose · Ophthalmology | $4,906 |
| Glaukos Corporation Apr 9, 2025 | Travel and Lodging Travoprost Intraocular Implant - iDose · Ophthalmology · travel to Los Angeles, CA | $122 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 3 companies. The companies reported $686,045 in research payments for these studies, mostly to the institutions running them.
- Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances
Oyster Point Pharma, Inc. · Completed · NCT06349759 - A prospective, multicenter study of the glaukos istent infinite trabecular micro-bypass system model IS3 in subjects with mild to moderate primary open-angle glaucoma
Glaukos Corporation - Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia
Oyster Point Pharma, Inc. · Completed · NCT06542497 - OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Oyster Point Pharma, Inc. · Recruiting · NCT07140783 - IStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
Glaukos Corporation - PMCS-010
Rxsight Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.